News

enroute carotid stent

Silk Road Medical Inc. announced the company received U.S. Food & Drug Administration (FDA) 510(k) clearance for its Enroute transcarotid neuroprotection system (NPS). The Enroute transcarotid...

Mitralign, six-month data, EuroPCR 2015, MPAS

Mitralign shared six-month data on its Mitralign Percutaneous Annuloplasty System (MPAS) for treatment of functional mitral regurgitation (FMR) at EuroPCR 2015 in Paris. The prospective, multi-...

National Security Technologies LLC (NSTec) and Henderson, Nevada-based Global Medical Isotope Systems (GMIS) announced a public-private partnership agreement for research and development of an...

Agfa HealthCare, Enteprise Imaging Exchange Program, SIIM 2015

Agfa HealthCare announced the launch of its Enterprise Imaging Exchange Program, which establishes a secure health information exchange network between multispecialty collaborating health...

Toshiba, Vantage Titan 3T, MR, magnetic resonance, upgrades, 2015

To meet both clinical and research needs of magnetic resonance (MR) customers, Toshiba America Medical Systems Inc. has implemented software and hardware upgrades for the Vantage Titan 3T MR...

HIMSS, CMS, comments, Meaningful Use, Stage 3

The Healthcare Information and Management Systems Society (HIMSS) submitted comments to the Department of Health and Human Services on the Meaningful Use Stage 3 proposed rule and the 2015 Edition...

Oxford Instruments plc has acquired Medical Imaging Resources Inc. (MIR). MIR specializes in the build, lease and service of mobile medical imaging labs.

CVRx, Barostim therapy, heart failure, trial, ESC-Heart Failure, Muller-Ehmsen

CVRx Inc. announced that positive results from the 'Barostim Therapy for Heart Failure' randomized, controlled clinical trial were presented at the ESC-Heart Failure 2015 Annual Conference in a...

electronic stents, bioresorbable electronic stent, BES

With the recent innovation of flexible microelectronic sensor circuits that can be made from bioresorbable materials, it is now possible to create “electronic stents” to monitor a treated lesion...

InvisionHeart, InvisionECG, FDA clearance

The U.S. Food and Drug Administration (FDA) has cleared the InvisionECG technology from InvisionHeart. The mobile electrocardiogram (ECG) technology uses a secure cloud-based, healthcare IT...

CyberHeart, Stony Brook, NSF grant, $4.2 million, Scott Smolka

A virtual-heart platform proposed by Stony Brook University researchers and colleagues has received funding from the National Science Foundation (NSF) in the amount of $4.2 million over five years...

OrbusNeich, Combo, EPC, HARMONEE study, U.S.

OrbusNeich has announced that the first U.S. patient has been enrolled in the HARMONEE (Harmonized Assessment by Randomized, Multi-center Study of OrbusNEich's COMBO StEnt) stent study. The study...

Kareo, Apple Watch App, practice efficiency, messaging, mobile devices

Kareo announced the launch of its Apple Watch App. This most recent innovation extends the functionality of the company’s electronic health record (EHR) to Apple Watch, streamlining care delivery...

Medic Vision Imaging Solutions Ltd. announced the introduction and availability of SafeCT Dose Reporting. Healthcare facilities can now, for the first time, use a single software platform to meet...

wearables, graphene, boron, Rice University

A microsupercapacitor designed by scientists at Rice University that may find its way into personal and even wearable electronics is getting an upgrade. The laser-induced graphene device benefits...

Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock

Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA Capital, Deerfield, Sectoral Asset...

Dassault Systemes, Living Heart model, 3-D simulator

Dassault Systèmes announced during its SIMULIA Community Conference that the first heart model from its “Living Heart Project” will be commercially available on May 29, 2015. Powered by Dassault...

Boston Scientific, Lotus, PVL, RESPOND, REPRISE II, EuroPCR 2015

A new study evaluating the Boston Scientific Lotus Valve System demonstrated an extremely low rate of paravalvular aortic regurgitation (leakage) for a transcatheter aortic replacement valve....

ART, PBS, pure bioresorbable scaffold, CE Mark

Privately-held company Arterial Remodeling Technologies (ART) announced CE Mark clearance for its next-generation drug-free, pure bioresorbable scaffold used to treat coronary artery disease. The...

At EuroPCR 2015, Mitralign presented updates on its mitral and tricuspid valve repair systems, including a presentation on six-month data on its Mitral system.